Publication

Complement activation in chronic kidney disease and dialysis

Gaya da Costa, M., 2019, [Groningen]: Rijksuniversiteit Groningen. 199 p.

Research output: ThesisThesis fully internal (DIV)Academic

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 1 MB, PDF document

  • Chapter 1

    Final publisher's version, 1 MB, PDF document

  • Chapter 2

    Final publisher's version, 2 MB, PDF document

  • Chapter 3

    Final publisher's version, 2 MB, PDF document

  • Chapter 4

    Final publisher's version, 1 MB, PDF document

  • Chapter 5

    Final publisher's version, 2 MB, PDF document

  • Chapter 6

    Final publisher's version, 2 MB, PDF document

    Embargo ends: 17/06/2020

  • Chapter 7

    Final publisher's version, 1 MB, PDF document

  • Chapter 8

    Final publisher's version, 1 MB, PDF document

    Embargo ends: 17/06/2020

  • Chapter 9

    Final publisher's version, 2 MB, PDF document

  • Chapter 10

    Final publisher's version, 1 MB, PDF document

  • Complete thesis

    Final publisher's version, 8 MB, PDF document

    Embargo ends: 17/06/2020

  • Propositions

    Final publisher's version, 18 KB, PDF document

Chronic kidney disease (CKD) is a growing health problem with a prevalence of approximately 10-15% worldwide. Progression of CKD leading to end-stage renal disease requires renal replacement therapy. In the Netherlands, approximately 6500 patients receive dialysis. Although dialysis is a life-saving treatment, the life expectancy and the quality of life of these patients is inferior to the general population. The complement system, the major part of the innate immune system, has been proposed to play a vital role in the inflammatory response induced by dialysis and could be the missing link between high morbidity and mortality and dialysis. In this thesis, we investigated the role of the complement system in different contexts: in healthy, CKD patients and during dialysis. We found that both types of dialysis, hemodialysis and peritoneal dialysis lead to complement activation. In hemodialysis patients, complement activation during the initial minutes of the hemodialysis session was related to the development of future cardiovascular event. Furthermore, in peritoneal dialysis complement activation occurred not only locally, in the peritoneal cavity, but also systemically. We also explored the complement activating ability of intravenous iron formulations, since CKD patients, dialysis dependents or not, commonly receive intravenous iron to control anemia. Finally, we unraveled the influence of age and sex on the complement system in healthy individuals. In conclusion, considering the link between complement activation and cardiovascular disease, targeting the complement system in CKD and dialysis is a potential strategy to improve outcome in these patients.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
  • van Son, Willem, Supervisor
  • Medina Pestana, Jose Osmar, Supervisor, External person
  • Seelen, Marc A J, Co-supervisor, External person
  • Poppelaars, Felix, Co-supervisor
  • Yard, B., Assessment committee, External person
  • Leuvenink, Henri, Assessment committee
  • Hillebrands, Jan Luuk, Assessment committee
Award date17-Jun-2019
Place of Publication[Groningen]
Publisher
Print ISBNs978-94-034-1692-2
Electronic ISBNs978-94-034-1691-5
Publication statusPublished - 2019

Download statistics

No data available

ID: 84208140